Entrada Therapeutics Cash from Operations (TTM) Analysis

Entrada Therapeutics Inc (TRDA)

17.20 -0.03 (-0.17%) USD | NASDAQ | Oct 31, 16:00

17.20 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
June 30, 2024	-14.19M
March 31, 2024	-89.12M
December 31, 2023	139.80M
September 30, 2023	116.51M
June 30, 2023	113.52M
March 31, 2023	130.60M

Date	Value
December 31, 2022	-93.79M
September 30, 2022	-87.02M
June 30, 2022	-73.62M
March 31, 2022	-63.52M
December 31, 2021	-50.86M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-93.79M

Minimum

Dec 2022

139.80M

Maximum

Dec 2023

2.576M

Average

-50.86M

Median

Dec 2021

Cash from Operations (TTM) Benchmarks